Long-term neuroepithelial-like stem cells (lt-NES) derived from human embryonic stem cells are a stable self-renewing progenitor population with high neurogenic potential and phenotypic plasticity. Lt-NES are amenable to regional patterning toward neurons and glia subtypes and thus represent a valuable source of cells for many biomedical applications. For use in regenerative medicine and cell therapy, lt-NES and their progeny require derivation with high-quality culture conditions suitable for clinical use. In this chapter, we describe a robust method to derive multipotent and expandable lt-NES based on good manufacturing practice and cell therapy-grade reagents. We further describe fully defined protocols to terminally differentiate lt-NES...
Abstract We have developed a good manufacturing practice for long‐term cultivation of fetal human mi...
# The Author(s) 2012. This article is published with open access at Springerlink.com Abstract Plurip...
Robust strategies for developing patient-specific, human, induced pluripotent stem cell (iPSC)-based...
Long-term neuroepithelial-like stem cells (lt-NES) derived from human embryonic stem cells are a sta...
Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) provide new prospects fo...
Background A major challenge for the clinical use of human pluripotent stem cells is the developmen...
Embryonic stem cells (ESCs) offer attractive prospective as potential source of neurons for cell rep...
Neuronal cell loss is a common feature of many neurological disorders, including stroke, Parkinson’s...
The study of neuronal differentiation of embryonic stem cells has raised major interest over recent ...
Summary: Here, we present a revised protocol to derive neuroepithelial stem (NES) cells from human i...
The availability of human neuronal progenitors (hNPs) in high purity would greatly facilitate neuron...
<p>(<b>A</b>) Representative pictures of the lt-NES cell lines PKa and AF22, derived from iPSCs gene...
Published in Journal of Neuroscience Research, 2004; 76 (2):184-192 at www.interscience.wiley.comThe...
Recent advances in stem cell technology afford an unlimited source of neural progenitors and glial c...
Robust strategies for developing patient-specific, human, induced pluripotent stem cell (iPSC)-based...
Abstract We have developed a good manufacturing practice for long‐term cultivation of fetal human mi...
# The Author(s) 2012. This article is published with open access at Springerlink.com Abstract Plurip...
Robust strategies for developing patient-specific, human, induced pluripotent stem cell (iPSC)-based...
Long-term neuroepithelial-like stem cells (lt-NES) derived from human embryonic stem cells are a sta...
Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) provide new prospects fo...
Background A major challenge for the clinical use of human pluripotent stem cells is the developmen...
Embryonic stem cells (ESCs) offer attractive prospective as potential source of neurons for cell rep...
Neuronal cell loss is a common feature of many neurological disorders, including stroke, Parkinson’s...
The study of neuronal differentiation of embryonic stem cells has raised major interest over recent ...
Summary: Here, we present a revised protocol to derive neuroepithelial stem (NES) cells from human i...
The availability of human neuronal progenitors (hNPs) in high purity would greatly facilitate neuron...
<p>(<b>A</b>) Representative pictures of the lt-NES cell lines PKa and AF22, derived from iPSCs gene...
Published in Journal of Neuroscience Research, 2004; 76 (2):184-192 at www.interscience.wiley.comThe...
Recent advances in stem cell technology afford an unlimited source of neural progenitors and glial c...
Robust strategies for developing patient-specific, human, induced pluripotent stem cell (iPSC)-based...
Abstract We have developed a good manufacturing practice for long‐term cultivation of fetal human mi...
# The Author(s) 2012. This article is published with open access at Springerlink.com Abstract Plurip...
Robust strategies for developing patient-specific, human, induced pluripotent stem cell (iPSC)-based...